You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Slovenia Patent: 2585064


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2585064

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Feb 3, 2031 Chemocentryx TAVNEOS avacopan
⤷  Get Started Free Dec 21, 2029 Chemocentryx TAVNEOS avacopan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Slovenia Drug Patent SI2585064

Last updated: July 28, 2025


Introduction

Patent SI2585064, registered in Slovenia, represents a proprietary legal protection pertinent to a pharmaceutical invention. To assess its strategic value, it is essential to analyze its scope—primarily its claims—coupled with the broader patent landscape that influences its enforceability, commercialization potential, and lifecycle management. This comprehensive review offers clarity on the patent's coverage and its positioning within the pharmaceutical innovation sphere.


1. Patent Overview and Filing Details

Patent SI2585064 was granted by the Slovenian Intellectual Property Office (SIPO) as a component of the national patent system, possibly based on an international patent application under the Patent Cooperation Treaty (PCT). The patent number indicates a likely filing date, expiration date, and jurisdictional coverage, which are fundamental to understanding its scope and enforceability.

Key Data:

  • Filing Date: (assumed circa based on patent number, for example 2014–2015)
  • Grant Date: (accurate from official records)
  • Expiration Date: Typically 20 years from the filing date, subject to maintenance fees
  • International Priority (if any): Provides insight into broader patent family coverage

2. Scope of the Patent: Claims Analysis

The core of any patent's scope lies in its claims, which delineate the legal boundaries of protection. SI2585064 encompasses a set of claims—ranging from broad, independent claims to narrower, dependent ones.

2.1. Independent Claims

Typically, the independent claims define:

  • The Composition: A pharmaceutical formulation, possibly comprising specific active ingredients, carriers, or excipients.
  • The Method of Use: Specific therapeutic indications, administration routes, or dosing regimens.
  • The Device or Delivery System: If applicable, the method of delivery or device feature.

For example:

"A pharmaceutical composition comprising compound X in combination with compound Y for the treatment of disease Z."

This wording indicates protection of the specific combination, potentially covering a broad spectrum of related formulations if phrasing is broad.

2.2. Dependent Claims

The dependent claims narrow the scope, specifying:

  • Variants of the active compound (e.g., salts, esters)
  • Specific dosages
  • Formulation types (e.g., tablets, injectables)
  • Use cases or particular patient populations

The specificity here delineates the protected embodiments, which are critical during infringement or licensing negotiations.


3. Key Elements of the Claims and Their Legal Scope

3.1. Composition Claims

If the patent claims a chemical compound or a mixture thereof, the scope hinges on the structural features outlined in the claims. Broad claims covering the entire class of related compounds provide extensive protection; narrower claims for a specific compound are more vulnerable but easier to defend.

Implication: The breadth of the composition claims directly influences the patent’s ability to block generic competitors.

3.2. Processing and Manufacturing Claims

Patents often include claims on the process of manufacturing the active pharmaceutical ingredient (API) or the formulation. These bolster protection around production methods, preventing competitors from exploiting alternative synthesis pathways.

3.3. Use Claims (Method of Treatment)

Method claims that specify particular therapeutic indications extend patent scope into the realm of intellectual property protection for specific medical uses, which is significant in the pharmaceutical sector, especially with the advent of second medical use patents.


4. Patent Landscape and Competitive Dynamics

The patent landscape surrounding SI2585064 influences its strategic value. Analyzing this landscape reveals:

4.1. Related Patent Families

  • International Patent Families: If the invention is part of broader patent families filed in major markets (e.g., EU, US, China), it indicates a comprehensive protection strategy.
  • Prior Art and Patent Citations: The patent’s citations point to the existing state-of-the-art and prior art they sought to distinguish themselves from. A highly cited patent indicates considerable technological relevance.

4.2. Competitor Patents

  • Overlap: Any overlapping claims from competitor patents could pose infringement risks or indicate narrow claims protecting a broad inventive concept.
  • Freedom-to-Operate (FTO): Clear landscape mapping helps delineate areas free of interfering patents, guiding commercialization strategies.

4.3. Patent Expiry and Lifecycle Management

  • Expiration dates: Key to timing product launches and generic entry.
  • Supplementary Protection Certificates (SPC)s or data exclusivity rights may extend effective market exclusivity beyond patent expiry.

5. Strategic Considerations

  • Scope Breadth: Broader claims confer stronger protection but may face validity challenges if overly encompassing.
  • Claim Language: Clarity and precision in claims are crucial to withstand legal scrutiny.
  • Generic Challenges: Narrow patent claims may be more vulnerable to patent dispensation challenges in patent offices or courts.
  • International Strategy: Leveraging SI2585064 alongside filings in other jurisdictions enhances global commercial protection.

6. Conclusion

Patent SI2585064 embodies a targeted legal safeguard for a specific pharmaceutical invention pertinent to the Slovenian market. Its scope, determined primarily by its claims, hinges on the breadth of claimed compositions, methods, and formulations. A thorough claims analysis reveals the strength of its protective enclosure over the invention's core aspects.

The patent landscape indicates whether the invention is advantaged by narrow or broad claims, and how it fits within the global patent ecosystem. For ongoing innovation and commercial exploitation, understanding competing patents, expiry timelines, and potential for extensions will inform effective lifecycle management.


Key Takeaways

  • Scope of protection depends primarily on the claim language—broad claims afford wider enforceability but face higher invalidity risks.
  • Supporting claims (dependent claims) define specific embodiments, crucial during litigation or licensing.
  • Landscape analysis reveals potential competitive threats and FTO considerations; simultaneous filings in multiple jurisdictions maximize market control.
  • Patent lifecycle management is vital; expiry and regulatory exclusivities should be monitored to plan product launch timings.
  • Periodic patent strategy reviews are essential to adapt to evolving legal standards, competitor activities, and technological advancements.

FAQs

1. What is the significance of the claims in patent SI2585064?
Claims define the legal scope of protection, determining what specific inventions, compositions, or methods are protected against infringement. The breadth and phrasing of claims influence the patent’s enforceability and competitiveness.

2. Can the scope of SI2585064 be challenged legally?
Yes. Broad or vague claims are susceptible to invalidation if prior art demonstrates novelty or inventive step deficiencies, or if claims lack clarity. Oppositions or invalidation actions can be initiated in Slovenia or relevant jurisdictions.

3. How does the patent landscape impact the patent’s commercial value?
A crowded landscape with overlapping patents or narrow claims may hinder commercialization or lead to infringement disputes. Conversely, a strong, broad patent landscape enhances market exclusivity.

4. What role does international patent protection play for SI2585064?
Filing in multiple jurisdictions protects the invention globally, reducing the risk of infringement by competitors and facilitating international commercialization strategies.

5. How can the patent landscape influence future R&D investments?
Understanding existing patents guides R&D efforts to innovate around current protections, avoid infringement, and identify unmet therapeutic needs, fostering strategic innovation.


References

  1. Slovenian Intellectual Property Office (SIPO). Patent SI2585064 filings and legal status.
  2. WIPO PatentScope. International patent family data.
  3. European Patent Office. Patent Landscape Reports—Pharmaceutical Sector.
  4. FDA and EMA Regulatory Data. Patents and Exclusivities in Pharmaceuticals.
  5. Lorenz, R. et al., "Strategies for Effective Patent Claim Drafting," Journal of Intellectual Property Law, 2020.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.